OLEMA PHARMACEUTICALS INC. - COMMON STOCK

Olema Oncology Reports Second Quarter 2022 Financial Results and Provides Corporate Update

09 Aug 2022 15:35:00 By Nasdaq GlobeNewswire

Olema Oncology Advances OP-1250 into Phase 2 Monotherapy Expansion in Patients with ER+/HER2- Advanced Breast Cancer

09 Aug 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology to Present at Canaccord Genuity 42nd Annual Growth Conference

04 Aug 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 Aug 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology Receives FDA Fast Track Designation for OP-1250 for the Treatment of ER+ / HER2- Metastatic Breast Cancer

21 Jul 2022 06:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 Jul 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology Provides Clinical Update Reflecting Strong Progress Across OP-1250 Development Program

09 Jun 2022 06:35:00 By Nasdaq GlobeNewswire

Olema Oncology and Aurigene Announce Exclusive Collaboration and License Agreement to Discover and Develop Novel Cancer Therapies

09 Jun 2022 06:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 Jun 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology to Present at Jefferies Healthcare Conference

24 May 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports First Quarter 2022 Financial Results and Provides Corporate Update

09 May 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 May 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18 Apr 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

04 Apr 2022 06:30:00 By Nasdaq GlobeNewswire

Olema Oncology Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022

08 Mar 2022 15:35:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

28 Feb 2022 15:30:00 By Nasdaq GlobeNewswire

Olema Oncology to Present at Cowen 42nd Annual Health Care Conference

22 Feb 2022 06:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 Feb 2022 16:00:00 By Nasdaq GlobeNewswire

Olema Oncology Appoints Naseem Zojwalla, M.D., as Chief Medical Officer

31 Jan 2022 06:30:00 By Nasdaq GlobeNewswire

Olema Oncology to Present at 40th Annual J.P. Morgan Healthcare Conference

04 Jan 2022 06:30:00 By Nasdaq GlobeNewswire